Adenovirus-delivered wwox inhibited lung cancer growth in vivo in a mouse model
Authors:
- 30 October 2015
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 23 (1) , 1-6
Abstract
Lung cancer is the most prevalent and deadly malignancy worldwide. This study investigated the possibility of inhibiting lung cancer in vivo with adenovirus-delivered WW domain-containing oxidoreductase (wwox). The lung cancer model was established by inoculating A549 lung cancer cells into the pleural space of nude mice. The control or wwox adenovirus was injected into the pleural space 7 days after cell inoculation and 14 days after first injection. The tumor number and burdens were measured 2 weeks after second virus injection. The carcinoembryonic antigen (CEA) and alpha-feto protein (AFP) levels in pleural effusion were analyzed by enzyme-linked immunosorbent assay. Apoptosis, proliferation and angiogenesis of tumor cells were assessed by terminal deoxinucleotidyl transferase-mediated dUTP-fluorescein nick end labeling assay, proliferating cell nuclear antigen (PCNA) and CD31 staining, respectively. Ectopic wwox significantly reduced both the number and size of lung tumors accompanied by substantially lower CEA and AFP levels in pleural effusion. The expression levels of Bcl2, Bcl-xL, vascular endothelial growth factor, PCNA-positive and CD31-positive cells in the tumors were significantly decreased, whereas levels of p21 and p73 and apoptotic cells markedly increased in mice receiving the wwox virus. These data demonstrated that wwox delivered by adenovirus was able to inhibit the growth of lung cancer in vivo, indicating the potential of using wwox as a gene therapy agent for lung cancer.Cancer Gene Therapy advance online publication, 30 October 2015; doi:10.1038/cgt.2015.56.Keywords
This publication has 18 references indexed in Scilit:
- Ectopic expression of the WWOX gene suppresses stemness of human ovarian cancer stem cellsOncology Letters, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- WWOX suppresses prostate cancer cell progression through cyclin D1-mediated cell cycle arrest in the G1 phaseCell Cycle, 2015
- TAp73 suppresses tumor angiogenesis through repression of proangiogenic cytokines and HIF-1α activityProceedings of the National Academy of Sciences, 2014
- A functional copy number variation in the WWOX gene is associated with lung cancer risk in ChineseHuman Molecular Genetics, 2013
- Functional and Clinical Characterization of the Putative Tumor Suppressor WWOX in Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- Bmi1 regulates cell fate via tumor suppressor WWOX repression in small‐cell lung cancer cellsCancer Science, 2011
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.2001
- WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.2000